Febrile Antibodies Identification Panel

Also known as: FBRL AB

Clinical Use

Use

The Febrile Antibodies Identification Panel is used to confirm the presence of diseases associated with febrile antibody responses. It is particularly useful in identifying infections such as brucellosis, Rocky Mountain spotted fever, and typhus fever by detecting specific antibodies in the patient's serum. A seroconversion, or a significant rise in antibody titers between acute and convalescent samples, is considered strong evidence of a recent infection. This test is not recommended for initial testing but serves to confirm disease presence in individuals with compatible clinical histories and symptoms.

Special Instructions

Not provided.

Limitations

The test may present cross-reactivity issues, notably between Brucella and Francisella tularensis antigens, which could lead to false-positive results if not interpreted in that context. Low levels of IgM antibodies may occasionally persist for more than 12 months after infection and could contribute to false positives, particularly in Rocky Mountain Spotted Fever diagnostics. As the antibodies' reactivity might include group reactivity, such as Typhus Fever group's Rickettsia prowazekii, interpretation of results should consider potential inclusivity of other organisms.

Test Details

New York Approved

Methodology

Immunoassay (Other)

Biomarkers

Brucella Ab (Total)Rocky Mt Spotted Fever IgGRocky Mt Spotted Fever IgMSalmonella paratyphi/typhi AntibodiesTyphus Fever Antibody, IgGTyphus Fever Antibody, IgM

LOINC Codes

Result Codes

19053-8 - Brucella Ab Titr Ser Aggl
5307-4 - R rickettsi IgG Titr Ser IF
5308-2 - R rickettsi IgM Titr Ser IF
5324-9 - R typhi IgG Titr Ser IF
5325-6 - R typhi IgM Titr Ser IF
17562-0 - Salmonella Ab Ser Ql

Result Turnaround Time

2-5 days

Specimen

Serum

Volume

2.5 mL

Minimum Volume

1.5 mL

Container

ARUP Standard Transport Tube

Collection Instructions

Collect serum using a Serum Separator Tube (SST). Remove serum from cells as soon as possible or within 2 hours of collection. Label specimens as acute or convalescent.